
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 10, 2025, titled "Completion of USFDA inspection in Ambernath facility".
Filed with NSE ·

Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 10, 2025, titled "Completion of USFDA inspection in Ambernath facility".
6ix hasn’t read this filing yet.
Solara Active Pharma Sciences Ltd. on 6ix
Follow Solara Active Pharma Sciences into a list and get an email when it puts out news.
Follow Solara Active Pharma Sciences